Manita Shyaula, Christina Khadka, Prabin Dawadi, Megha Raj Banjara
{"title":"尼泊尔产肺炎克雷伯菌的广谱β-内酰胺酶的系统评价和meta分析。","authors":"Manita Shyaula, Christina Khadka, Prabin Dawadi, Megha Raj Banjara","doi":"10.1177/11786361221145179","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>This systematic review and meta-analysis aimed to assess the pool estimates of extended-spectrum β-lactamases producing <i>K. pneumoniae</i> (ESBL-KP) and study their drug resistance profile by evaluating the studies from Nepal.</p><p><strong>Methods: </strong>A literature search was carried out in PubMed, Google Scholar, and NepJOL to screen all articles on ESBL-KP published between 2011 and 2021 from Nepal. This review was conducted following Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines. Relevant data were extracted, and R language 4.2.0 software was used for statistical analysis.</p><p><strong>Results: </strong>The pooled prevalence of <i>K. pneumoniae</i> was 5%, while the pooled prevalence of ESBL and multidrug resistance (MDR) in <i>K. pneumoniae</i> were 23% and 55%, respectively. Imipenem was the drug of choice (in vitro) against ESBL-KP infection.</p><p><strong>Conclusion: </strong>Our analyses showed a high prevalence of ESBL-KP and their high resistance toward commonly used drugs. This study highlights the need for the development of new antibiotics for the management of ESBL-KP infections.</p>","PeriodicalId":74187,"journal":{"name":"Microbiology insights","volume":"16 ","pages":"11786361221145179"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/18/cf/10.1177_11786361221145179.PMC9841864.pdf","citationCount":"1","resultStr":"{\"title\":\"Systematic Review and Meta-analysis on Extended-Spectrum β-lactamases Producing <i>Klebsiella pneumoniae</i> in Nepal.\",\"authors\":\"Manita Shyaula, Christina Khadka, Prabin Dawadi, Megha Raj Banjara\",\"doi\":\"10.1177/11786361221145179\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>This systematic review and meta-analysis aimed to assess the pool estimates of extended-spectrum β-lactamases producing <i>K. pneumoniae</i> (ESBL-KP) and study their drug resistance profile by evaluating the studies from Nepal.</p><p><strong>Methods: </strong>A literature search was carried out in PubMed, Google Scholar, and NepJOL to screen all articles on ESBL-KP published between 2011 and 2021 from Nepal. This review was conducted following Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines. Relevant data were extracted, and R language 4.2.0 software was used for statistical analysis.</p><p><strong>Results: </strong>The pooled prevalence of <i>K. pneumoniae</i> was 5%, while the pooled prevalence of ESBL and multidrug resistance (MDR) in <i>K. pneumoniae</i> were 23% and 55%, respectively. Imipenem was the drug of choice (in vitro) against ESBL-KP infection.</p><p><strong>Conclusion: </strong>Our analyses showed a high prevalence of ESBL-KP and their high resistance toward commonly used drugs. This study highlights the need for the development of new antibiotics for the management of ESBL-KP infections.</p>\",\"PeriodicalId\":74187,\"journal\":{\"name\":\"Microbiology insights\",\"volume\":\"16 \",\"pages\":\"11786361221145179\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/18/cf/10.1177_11786361221145179.PMC9841864.pdf\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Microbiology insights\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/11786361221145179\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Microbiology insights","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/11786361221145179","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Systematic Review and Meta-analysis on Extended-Spectrum β-lactamases Producing Klebsiella pneumoniae in Nepal.
Objective: This systematic review and meta-analysis aimed to assess the pool estimates of extended-spectrum β-lactamases producing K. pneumoniae (ESBL-KP) and study their drug resistance profile by evaluating the studies from Nepal.
Methods: A literature search was carried out in PubMed, Google Scholar, and NepJOL to screen all articles on ESBL-KP published between 2011 and 2021 from Nepal. This review was conducted following Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines. Relevant data were extracted, and R language 4.2.0 software was used for statistical analysis.
Results: The pooled prevalence of K. pneumoniae was 5%, while the pooled prevalence of ESBL and multidrug resistance (MDR) in K. pneumoniae were 23% and 55%, respectively. Imipenem was the drug of choice (in vitro) against ESBL-KP infection.
Conclusion: Our analyses showed a high prevalence of ESBL-KP and their high resistance toward commonly used drugs. This study highlights the need for the development of new antibiotics for the management of ESBL-KP infections.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
